For the latest blog post of PHAROS Healthcare Consulting EUROPE, Axtalis has provided an overview on the decision of Ernst Kuipers, #Dutch #minister of #health, Welfare and Sport, who specified to adapt the rules for admission of new expensive #drugs in the Netherlands from the 1st of July 2023.
Check the full block post on the PHAROS website!